Llwytho...
A human-on-a-chip approach to tackling rare diseases
Drug development for rare diseases, classified as diseases with a prevalence of <200 000 patients, is limited by high cost of research and low target population. Owing to a lack of representative disease models, research has been challenging for orphan drugs. Human-on-a-chip (HoaC) technology, wh...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Drug Discov Today |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856435/ https://ncbi.nlm.nih.gov/pubmed/31412288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2019.08.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|